ESC2025 Premium Access

The importance of coronary flow velocity reserve in predicting cardiac mortality and heart failure in hypertrophic cardiomyopathy

Congress Presentation

About the speaker

Associate Professor Milorad Tesic

University Clinical Center of Serbia, Belgrade (Serbia)
0 follower

5 more presentations in this session

Safety, tolerability, pharmacokinetics and pharmacodynamics of HRS-1893 in patients with obstructive hypertrophic cardiomyopathy: a randomized, double-blind, placebo-controlled phase 1 trial

Speaker: Doctor X. Wu (Beijing, CN)

Thumbnail

Real-world outcomes of mavacamten for symptomatic obstructive hypertrophic cardiomyopathy: global evidence from COLLIGO-HCM

Speaker: Doctor A. Adler (Toronto, CA)

Thumbnail

The icelandic hypertrophic cardiomyopathy project: a recall-by-genotype study on MYBPC3 founder mutation carriers. echocardiographic data and b-type natriuretic peptide measurement.

Speaker: Doctor O. Gunnarsdottir (Reykjavik, IS)

Thumbnail

Multiparametric CMR detects a higher burden of microstructural and metabolic abnormalities in sarcomeric HCM compared to non-sarcomeric HCM

Speaker: Doctor Z. Ashkir (Oxford, GB)

Thumbnail

Extended holter monitoring in hypertrophic cardiomyopathy: the predictive value of early versus late nonsustained ventricular tachycardia detection

Speaker: Doctor C. Chaumont (Rouen, FR)

Thumbnail

Access the full session

Advancing care in hypertrophic cardiomyopathy

Speakers: Associate Professor M. Tesic, Doctor X. Wu, Doctor A. Adler, Doctor O. Gunnarsdottir, Doctor Z. Ashkir...
Thumbnail

About the event

Image

ESC Congress 2025

29 August - 1 September 2025

Sessions Presentations